Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared on X:
“ADCs remain hot after ASCO2024 — check out our pan-tumoral analysis of TROP2 among solid tumors.”
Read further.
Source: Samuel Kareff/X